Skip to main content
TipRanks
Go Ultimate75% OFF

Apimeds Pharmaceuticals US, Inc. (APUS) Stock Forecast & Price Target

31 Followers
See the Price Targets and Ratings of:

APUS Analyst Ratings

Currently, no data available

APUS Stock 12 Month Forecast

There Are No Analyst Ratings for APUS In The Last 3 Months.

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for APUS
Price TargetArticle
TipRanks - PerPlexity$2→$1.50sell-6.25%DownsideReiterated11/20/26
TipRanks - Google$2→$1.50hold-6.25%DownsideReiterated11/20/26
TipRanks - Anthropic$2→$1.50hold-6.25%DownsideReiterated11/20/26
TipRanks - OpenAI$2→$1.50hold-6.25%DownsideReiterated11/20/26
TipRanks - DeepSeek$2→$1.50hold-6.25%DownsideUpgraded11/20/26
TipRanks - xAI$2→$1.50hold-6.25%DownsideReiterated11/20/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
IMUXImmunic
MDWDMediwound
PTGXProtagonist Therapeutics
KRSAKorsana Biosciences
AXGNAxoGen

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Apimeds Pharmaceuticals US, Inc.

3 Months
PerPlexity Biotechnology
PerPlexity BiotechnologyTipRanks - PerPlexity
Success Rate0/1 ratings generated profit
0%
Average Return
0.00%

Copying PerPlexity Biotechnology's trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of 0.00% per trade.

1 Year
PerPlexity Biotechnology
PerPlexity BiotechnologyTipRanks - PerPlexity
Success Rate0/1 ratings generated profit
0%
Average Return
0.00%

Copying PerPlexity Biotechnology's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of 0.00% per trade.

2 Years
PerPlexity Biotechnology
PerPlexity BiotechnologyTipRanks - PerPlexity
Success Rate0/1 ratings generated profit
0%
Average Return
0.00%

Copying PerPlexity Biotechnology's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of 0.00% per trade.

APUS Analyst Recommendation Trends

00.511.52Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26
Monthly rating counts for APUS
RatingJul 26Aug 26Sep 26Oct 26Nov 26
Strong Buy00000
Buy00000
Hold00000
Sell00000
Strong Sell00000
total00000

In the current month, APUS has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. APUS average Analyst price target in the past 3 months is ―.

APUS Financial Forecast

APUS Stock Forecast FAQ

Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
What do analysts say about Apimeds Pharmaceuticals US, Inc.?
Not enough analysts have published a price target to provide an average price target.
How can I buy shares of APUS?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.